This article was originally published June 30.
Next-gen sequencing service provider Cofactor Genomics said last week that it has installed an Applied Biosystems SOLiD 4 sequencer and plans to use the instrument to sequence the genome of British heavy metal legend Ozzy Osbourne.
For the project, St. Louis-based Cofactor Genomics will construct and sequence DNA libraries, while direct-to-consumer genome analysis firm Knome will analyze and interpret the data.
According to Sky News, which first reported the project in June, the goal is to determine how Osbourne "is still alive after decades of drug and alcohol abuse."
The project is another example of celebrity genome sequencing: in March, Illumina said that it had sequenced the genome of American actress Glenn Close on its Genome Analyzer platform.
Cofactor Genomics, founded in 2008 by former scientists of the Genome Center at Washington University, focuses exclusively on next-gen sequencing services (IS 12/2/2008) and currently has the Illumina and SOLiD platforms in house.